Navigation Links
ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting

MONTGOMERY, Ala.--(BUSINESS WIRE)--Jun 8, 2007 - ProEthic Pharmaceuticals, Inc., a privately funded specialty pharmaceutical company that acquires, develops, licenses, and markets niche prescription products, today presented detailed Phase III study data for PRO-513, the Company's product candidate for the treatment of migraine headaches. The results were presented in two poster presentations at the American Headache Society's 49th Annual Scientific Meeting in Chicago by Richard B. Lipton, MD, Professor and Vice Chair of Neurology at the Albert Einstein College of Medicine and Director of the Montefiore Headache Center. The findings showed that PRO-513 relieved the pain of migraine for patients within 30 minutes, reduced the associated symptoms of the migraine attack and that its benefits persisted up to 24 hours.

The first poster presentation provided efficacy and tolerability results from a Phase III clinical study for PRO-513, a randomized, double-blind, placebo-controlled trial that enrolled 690 adult patients.

The two-hour pain free response among patients, the primary efficacy endpoint of the trial, was 25 percent in the PRO-513 arm of the trial versus 10 percent for the placebo arm (P less than 0.001). In addition, the two-hour pain headache response for the PRO-513 arm of the trial was 65 percent, compared with 41 percent for the placebo group. Statistically significant differences in pain intensity difference (PID) scores emerged at 30 minutes (P=0.013) and the PID remained significant at P less than 0.001 at each of the subsequent 10 time points measured.

The findings also demonstrated that the proportion of patients who were free of symptoms accompanying migraine was statistically significant for PRO-513 compared to placebo at two hours for nausea (P=0.002), photophobia, or sensitivity to light (P less than 0.001) and phonophobia, or sensitivity to sound (P less than 0.001).

The
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:9/17/2014)... , Sept. 17, 2014 BRIC Biopsy Devices ... GlobalData,s new report, "BRIC Biopsy Devices Market Outlook ... Biopsy Devices market. The report provides value, in millions ... (in US dollars) within market segments - Biopsy Guns ... Fine Aspiration Needles (Disposable and Reusable Fine Aspiration Needles) ...
(Date:9/17/2014)... , Sept. 17, 2014  Levi & Korsinsky, ... connection with possible claims of breaches of fiduciary duty ... To get more information, click here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa ... If you own common stock in Alexza ... contact Eduard Korsinsky, Esq. either via email ...
(Date:9/17/2014)... Sept. 17, 2014 Prostate Oncology Specialists ... campaign to educate men about new imaging technology ... the prostate. Annually, a million men undergo random ... rectum. Multi-parametric MRI (MP-MRI) of the prostate gland is ... Men need to be fully informed of their ...
Breaking Medicine Technology:BRIC Biopsy Devices Market Outlook to 2020 2BRIC Biopsy Devices Market Outlook to 2020 3Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3
... Alcohol Abuse Among ADHD Patients Nearly Triple ... People, INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- ... (atomoxetine HCl),improved symptoms of Attention- Deficit/Hyperactivity Disorder,(ADHD) ... suggesting,ADHD can be treated safely and effectively ...
... Otsuka Pharmaceutical Co, Ltd. Sponsored Study,Presented at ... SAN DIEGO, May 23, 2007 /PRNewswire/ -- ... years old) with schizophrenia, the Otsuka,Pharmaceutical Co., ... demonstrated significant improvement,compared to placebo on the ...
Cached Medicine Technology:Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9
(Date:9/18/2014)... (PRWEB) September 18, 2014 A positive outlook ... and improve your health. This year, at the Weekend for ... announce that adored LA radio talk show host Mother Love ... living with diabetes. , The always-funny Jo Anne Hart, ... is best known for her widely acclaimed talk show on ...
(Date:9/18/2014)... It is true that a business-oriented hosting solution ... brand or business online. Best Cheap Hosting USA, ... of professional web hosting suppliers and announced that ... the best VPS hosting suppliers in 2014. , ... businesses or enterprises can find the right hosting ...
(Date:9/18/2014)... September 18, 2014 Finding the perfect ... many dieters feeling that their weight loss struggle will ... trained in the science of fast weight loss, patients ... negative side effects. In fact, a recent in-house survey ... an average of 20 pounds during the first month ...
(Date:9/18/2014)... 2014 Texas Physical Therapy Specialists (TexPTS) ... Hispanic Physicians Association (HPA) Friends and Family Golf ... Texas. , The tournament, which will take place at ... for student scholarships through three golf challenges, “Top Scramble”, ... Equipment is provided at the event and there ...
(Date:9/18/2014)... SMI (Silicon Microstructures, Inc.) ... sensor Series designed especially for cost sensitive applications ... and differential offering allows for optimal signal resolution ... accuracy provide the user high performance while the ... reliability and long-term reliability needed for critical applications. ...
Breaking Medicine News(10 mins):Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2Health News:Best Cheap Hosting USA: GreenGeeks, Arvixe And iPage Are The Best Hosting Suppliers In 2014 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 2Health News:Diet Doc Discloses the Results of a Recent In-House Survey Revealing an Average Loss of 20 Pounds Per Month with Their No Carb Diet Plans 3Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:SMI Launches Digital MEMS Low Pressure Sensor 2
... (HealthDay News) -- Cardiac arrest victims are more likely to ... and after using a defibrillator to deliver an electric shock ... the cases of 815 American and Canadian patients who suffered ... (EMS) paramedics using either an automated external defibrillator or a ...
... WASHINGTON Synthetic fat substitutes used in low-calorie potato ... weight gain and obesity, according to a study published ... researchers at Purdue University, challenges the conventional wisdom that ... "Our research showed that fat substitutes can interfere with ...
... MONDAY, June 20 (HealthDay News) -- The U.S. Food and ... the safety and quality of imported drugs and food products. ... and increased data sharing, was created in response to rapidly ... chain. The strategy is outlined in a special report called ...
... the weather gets warmer, many parents will turn to pools ... and ease of use, portable pools - which include wading ... an increasingly popular alternative to expensive in-ground pools or water ... for children to cool off during hot summer days, a ...
... Cambridge University has for the first time found that ... The Medical Research Council (MRC) funded study, published ... Disorders , has important implications for service provision in ... Professor Simon Baron-Cohen, Director of the Autism Research ...
... ON (June 20, 20122) - Women with urinary incontinence ... develop postpartum depression as those without incontinence, according to ... in McMaster University,s School of Nursing. Postpartum depression ... in the family. According to the Canadian Mental Health ...
Cached Medicine News:Health News:Faster Transition From CPR to Defibrillator May Save Lives 2Health News:Fat substitutes linked to weight gain 2Health News:FDA to Step Up Inspections of Imported Products 2Health News:New study uncovers the dangers of portable pools 2Health News:Diagnosed autism is more common in an IT-rich region 2Health News:Diagnosed autism is more common in an IT-rich region 3Health News:Urinary incontinence doubles risk of postpartum depression 2
... hands play an important part in our ... and rheumatic changes can cause severe handicaps. ... the finger-joint prostheses was to produce a ... natural function as nearly possible.,The cementless RM ...
... hands play an important part in our ... and rheumatic changes can cause severe handicaps. ... the finger-joint prostheses was to produce a ... natural function as nearly possible.,The cementless RM ...
... precise control of the thigh during varus/valgus manipulation ... the proximal thigh during ACL or PCL procedures. ... on both right and left legs and may ... Holder can be used with an Arthrex tourniquet ...
... for trauma, foot and ankle or deformity ... External Fixation components are designed to reduce ... the complexity of intra-operative and post-operative frame ... and hinges eliminate the need to stock ...
Medicine Products: